Walleye Capital’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.01K Hold
200
﹤0.01% 4198
2025
Q4
$5.27K Buy
+200
New +$4.36K ﹤0.01% 4334
2023
Q4
Sell
-5,600
Closed -$35.5K 5619
2023
Q3
$35.5K Buy
+5,600
New +$41.4K ﹤0.01% 4271

Other funds holding ZYME

Walleye Capital's ZYME Position: Q1 2026 in Review

Walleye Capital reduced its Zymeworks (ZYME) stake by 99% in Q1 2026, selling an estimated $322K and leaving 78 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #4238.

Walleye Capital first reported a position in ZYME in Q1 2022 and has held it in 9 quarters since. The position peaked at $6.63M in Q4 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Walleye Capital held 78 shares of Zymeworks worth $1.95K as of Q1 2026.
  • Walleye Capital sold 13,589 Zymeworks shares in Q1 2026, an estimated $322K.
  • Zymeworks made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4238 holding.
  • Walleye Capital first reported a position in Zymeworks in Q1 2022 and has held it in 9 quarters since.
  • Walleye Capital's Zymeworks position peaked at $6.63M in Q4 2024.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.